E-LIB Suche - Ergebnisse für: Howard Jr., JF

1

P.057 Achievement of minimal symptom expression in acetylch..:

Bril, V ; Muppidi, S ; Howard Jr., JF...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S31-S31 , 2024

Link: https://doi.org/10.1017/..

2

P.055 Corticosteroid dose tapering in patients with general..:

Genge, A ; Hewamadduma, C ; Freimer, M...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S31-S31 , 2024

Link: https://doi.org/10.1017/..

3

P.054 Long-term safety and efficacy of zilucoplan in myasth..:

Genge, A ; Howard Jr., JF ; Freimer, M...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S30-S31 , 2024

Link: https://doi.org/10.1017/..

4

P.045 Safety profile overview of Efgartigimod Clinical Tria..:

Bril, V ; Behin, A ; Gwathmey, K...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S70-S70 , 2023

Link: https://doi.org/10.1017/..

5

P.044 Efficacy, safety, and tolerability of efgartigimod in..:

Bril, V ; Vu, T ; Karam, C...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S70-S70 , 2023

Link: https://doi.org/10.1017/..

6

P.040 Long-term efficacy and safety of ravulizumab in adult..:

Vu, T ; Meisel, A ; Mantegazza, R...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S68-S69 , 2023

Link: https://doi.org/10.1017/..

7

P.034 Minimal symptom expression following treatment with e..:

Siddiqi, Z ; Howard Jr, JF ; Bril, V...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S67-S67 , 2023

Link: https://doi.org/10.1017/..

8

P.043 Long-term safety, tolerability, and efficacy of efgar..:

Genge, A ; Pasnoor, M ; Bril, V...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S69-S69 , 2023

Link: https://doi.org/10.1017/..

9

Ravulizumab in Myasthenia Gravis: A Review of the Current E..:

Vu T ; Wiendl H ; Katsuno M..
https://www.dovepress.com/ravulizumab-in-myasthenia-gravis-a-review-of-the-current-evidence-peer-reviewed-fulltext-article-NDT. , 2023

Link: https://doaj.org/article..

10